SCHEMBL2816601

SCHEMBL2816601

COc1ccc(C(=O)Nc2cccc(C(C)(C)CNC(=O)c3nn(C)c4ccccc34)c2)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.46
ALDH1A1 P00352 2/20 0.46
CPT1A P50416 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
NPC1 O15118 1/20 0.43
NQO2 P16083 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
MAPT P10636 4/20 0.43
NPSR1 Q6W5P4 2/20 0.42
TSHR P16473 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SENP5 Q96HI0 1/20 0.42
SENP2 Q9HC62 1/20 0.42
SENP1 Q9P0U3 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2818047 0.87 LCK (0.45) POLBALDH1A1CPT1AMEN1KMT2A
SCHEMBL2813694 0.86 CPT1A (0.45) POLBCPT1AMEN1KMT2ALMNA
SCHEMBL2816699 0.86 CPT1A (0.45) POLBALDH1A1CPT1AMEN1KMT2A
SCHEMBL2819888 0.82 FLT3 (0.54) POLBALDH1A1LMNANPC1L3MBTL1
SCHEMBL2814215 0.80 POLB (0.65) POLBALDH1A1MEN1KMT2ALMNA
SCHEMBL2816689 0.79 MEN1 (0.53) POLBALDH1A1MEN1KMT2ALMNA
SCHEMBL2819890 0.75 ROCK1 (0.46) POLBALDH1A1CPT1AMEN1KMT2A
SCHEMBL2813768 0.75 POLB (0.62) POLBALDH1A1MEN1KMT2ALMNA
SCHEMBL4555728 0.73 FLT3 (0.55) ALDH1A1MEN1KMT2ALMNANPC1
SCHEMBL2817833 0.73 MEN1 (0.48) POLBALDH1A1MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2010-09-30 US disclosed
EP-2134676-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE Addex Pharma SA (CH) 2009-12-23 EP disclosed
WO-2008117175-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE FSHR, GNRHR, SHBG POLB 3820/4885ALDH1A1 1769/4885CPT1A 4075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.